INTRODUCTION
============

Glycine receptors (GlyRs) are mainly known by their function in spinal circuits. They are widely expressed in the spinal cord where they contribute to synaptic transmission ([@B19]; [@B85]; [@B109]), and play an important role in motor control ([@B104]), and pain perception ([@B44]; [@B134]; [@B75]). They appear early during spinal cord development and their subunit composition is developmentally regulated ([@B126]). Interestingly, it has been shown that GlyRs influence spinal development by affecting interneuron differentiation ([@B84]) and synaptogenesis ([@B109]). Although the occurrence of functional GlyRs in the adult brain was already described two decades ago ([@B77]; [@B15]), little is known regarding their function in supratentorial regions. It is believed that GlyRs mainly mediate extra-synaptic tonic inhibition in the hippocampus ([@B114]; [@B57]; [@B135]; [@B129]; [@B2]). Moreover, synaptic GlyRs have also been identified in the brain cortex ([@B125]), excitatory, and inhibitory hippocampal neurons ([@B11]; [@B23]; [@B63]; [@B129]), the cerebellum ([@B97]), and thalamic ([@B39]) and brainstem nuclei ([@B120]). In addition, disruption of GlyRs activity contributes to brain pathologies. Alternative splicing variants have been detected in patients suffering from temporal lobe epilepsy ([@B33]). Moreover, mutations in genes encoding either the GlyR alpha 2 subunit ([@B98]) or the aminomethyltransferase enzyme (AMT), which is an important factor involved in the degradation of glycine ([@B133]), have been found in patients affected by autism.

GlyRs are trans-membrane protein complexes formed by the assembling of five subunits arranged symmetrically around a central pore. Five types of GlyR subunits, four alphas and one beta, have been described so far ([@B83]; [@B74]). Moreover, alternative splicing can generate additional variants for some alpha subunits ([@B64]; [@B76]; [@B91]; [@B70]). Alpha subunits can form homo- or heteromeric receptors in combination with the beta subunit ([@B101]; [@B94]). The alpha one/beta combination displays the fastest kinetic and has been associated with mature synapses mediating fast inhibitory neurotransmission, mainly in the spinal cord and in the brainstem. In addition, the beta subunit is the only one able to interact with gephyrin and, hence, provides an anchoring mechanism necessary for synaptic localization and function ([@B60]). Complementarily, alpha two containing receptors, which display slower kinetics characterized by a slower desensitization, are abundant during development and have been found in extra-synaptic locations. Besides glycine, GlyRs can also be activated by other ligands, such as taurine and alanine ([@B110]; [@B58]). Each of these molecules can bind to the extracellular domain and promote the opening of the central pore that allows the selective flux of chloride and bicarbonate ions. In the same way as for type A gamma-aminobutyric acid receptors (GABA~A~R), GlyR-mediated anion flux is solely dependent on the electrochemical gradient established across the cell membrane for these ions.

During development, chloride gradients evolve in function of the expression of chloride transporters. In neurons, the potassium-chloride cotransporter 2 (KCC2) actively reduces the intracellular concentration of chloride, transforming the opening of a chloride channel into a hyperpolarizing stimulus ([@B69]; [@B136]). Conversely, the sodium-potassium-chloride co-transporter (NKCC1) exerts the opposite effect and thus increases the intracellular concentration of chloride transforming the ion channel-mediated chloride flux into a depolarizing signal. In consequence, GlyR activation during embryonic and early postnatal development most likely induces a depolarization of the cell membrane ([@B36]; [@B59], [@B58]) which in turn may activate calcium influx ([@B100]; [@B132]). Compared to glutamate-mediated depolarization, chloride efflux is thought to be less harmful to the cell since there is no risk to induce excitotoxicity. This is a remarkable feature shared with GABA~A~Rs-mediated signaling during development and has been associated with developmental functions.

Here, we review the accumulating literature regarding the role of GlyRs during embryonic and postnatal brain development. We discuss this literature in the context of recent findings about the cellular and molecular events that govern brain development and we provide insight into the processes in which these receptors may be involved.

GLYCINE RECEPTORS DURING EMBRYONIC BRAIN DEVELOPMENT
====================================================

Brain development is a long process that starts early during embryogenesis and takes years to be completed in humans. The initial steps involve precise coordination of cell proliferation, differentiation, and cell migration. Tight control of these processes is achieved by integration of the intrinsic genetic program with the extracellular signals present in the biochemical environment ([@B99]; [@B14]). Interestingly, neurotransmitters and their receptors are part of this biochemical environment and contribute to early steps of neurogenesis ([@B90]; [@B116]; [@B45]). GlyR expression in the CNS was first studied using radioactive labeled strychnine; however, this approach only identified high affinity receptors, which are mostly absent during development ([@B37]; [@B102]). To circumvent this problem, Malosio and colleagues used *in situ* hybridization to assess the presence of various GlyR subunits in the rat embryonic brain ([@B64]; [@B77]). In this study, the authors found abundant expression of both alpha 2 and beta subunits during prenatal stages. The messenger RNA (mRNA) for the alpha 2 subunits was the most widely expressed and it was detected since embryonic day 14 (E14) onwards in all layers of the cortex during the whole embryonic period ([@B77]). This mRNA was also found in the diencephalon and midbrain, at E14, and in the thalamus and cerebellum primordium, at E19. The beta subunit mRNA was found mainly in the cortex at E14, where it was distributed homogenously. However, at E19 the expression pattern became more restricted and only layers I and II were labeled. Interestingly, at E19 the cerebellum was also selectively labeled with the GlyR beta subunit-directed probes. No other GlyR subunits were detected in the brain, but it is important to note that the expression of the GlyR alpha 4 subunit has not yet been studied at this age. Additionally, at E19, immunostainings detected GlyR in radially oriented neurons in the intermediated zone (IZ) and cortical plate (CP; [@B36]). Recently, western blot analysis and immunolabeling have been used to demonstrate the presence of GlyR alpha 2 subunit in migratory interneurons isolated from the brain cortex at the E13 ([@B3]). Protein expression was found on progenitors as well as on migrating neurons at this age. This was a first step to further study the involvement of GlyRs on interneuron development (see below).

Contrasting with the accumulating evidence regarding GlyR expression during cortical development, there is only limited information about the functionality and physiological relevance of these receptors in the embryonic brain. To examine when functional GlyRs first appear during cortical neurogenesis, [@B36] recorded glycine and taurine elicited currents in different zones of the embryonic cortex at E19. Interestingly, all recorded neurons in the CP and IZ showed GlyR-mediated responses. In contrast, none of the cells located in the ventricular zone (VZ) seemed to have functional GlyRs ([@B36]). These results were confirmed by immunohistochemical analyses, which showed intense labeling in the IZ and CP, but not in the VZ. Single cell resolution was achieved in the IZ where GlyR expression was localized in the soma and apical leading process ([@B36]). Complementarily, *in vitro* experiments, carried out at E17 in rats, demonstrated that newborn projection neurons already express GlyRs, along with GABA~A~Rs and voltage-gated ion channels at this age, by the end of their radial migration ([@B93]). Calcium measurements have provided further evidence about the presence and function of GlyRs in the embryonic cortex. Consistent with a depolarizing effect, it was shown that glycine application triggers a massive calcium influx in the upper-layer pyramidal neurons at E17. This effect was blocked by strychnine and totally absent in the GlyR-knockout (KO) animals ([@B132]). More interestingly, the same effect was recorded very early during cortex development, at E13 ([@B100]). At this age, GlyRs were shown to have a unique role in preplate (PP) neurons, which are depolarized in response to GlyR activation. This depolarization activates voltage-sensitive sodium channels that subsequently activate sodium-sensitive calcium transporters. This complex channel association leads to the rise in intracellular calcium and promotes vesicular release of glutamate ([@B100]). Importantly, this role was exclusively mediated by GlyRs and did not involve the activation of co-expressed GABA~A~Rs. Moreover, released glutamate amplified GlyR-mediated signaling, and triggered calcium influx in the VZ as well ([@B100]). Complementarily, it has recently been shown that differentiated human midbrain-derived cells express functional GlyRs that respond to glycine with low affinity, whose activation can trigger calcium influxes ([@B127]). These cells were obtained from 10 to 16 weeks human fetuses and kept in culture for 1--3 weeks. After that period, they expressed GlyRs, but they had limited impact on neurogenic capability and cell differentiation towards dopaminergic neurons ([@B127]). Thus, the impact of GlyRs activation on cell differentiation remains poorly understood.

GLYCINE RECEPTORS AND CELL MIGRATION IN THE DEVELOPING BRAIN
------------------------------------------------------------

Recently, we have gained a better understanding of the mechanisms that control this process and the role of extracellular factors involved. Interestingly, calcium-dependent processes seem to be fundamental for transducing molecular signalings associated with activation of neurotransmitter receptors. Indeed, it has been demonstrated that the secondary activation of voltage-gated calcium channels (VGCCs) is necessary to mediate GABA actions on cell migration ([@B10]) and proliferation ([@B72]; [@B96]). Along this line, a short report has suggested that GlyR could have an influence in radial migration during late embryonic development ([@B92]). Application of glycine was shown to impede radial migration in agreement with the effect caused by the activation of type C GABA receptors (GABA~C~Rs; [@B25]), but opposed to the effects of GABA acting at GABA~A~R activation that rather promotes radial migration ([@B78]). As an explanation to the opposite effects exerted by the activation of GABA receptors it has been proposed that GABA~C~Rs could exert their effect by an ion-independent process ([@B25]). This could be a likely hypothesis to explain migration arrest caused by GlyRs activation. Moreover, GlyRs could also act using non-autonomous mechanisms. As it has been presented, GlyRs are distributed throughout the whole cortex at this age and they may contribute to different processes to indirectly control cell migration. Nevertheless, the role of GlyRs in controlling radial cell migration remains to be demonstrated *in vivo*. On the other hand, the role of GlyRs in controlling interneurons migration has recently become clearer. Specifically, it has been demonstrated that GlyR activation can trigger a series of intracellular events in cortical interneurons that leads to the modulation of interneuron migration during embryonic development ([@B3]). Molecular events triggered by GlyR activation include the secondary activation of VGCC that leads to the influx of calcium and to the modulation of spontaneous oscillations. Calcium influx, mediated by the activation of L-type channels, indirectly leads to the modulation of myosin activity and to changes in actomyosin contractions at the rear of the migratory neurons. This further modifies interneuron nucleokinesis and affects interneuron migration speed ([@B3]). These findings provide evidence for a role of GlyRs in interneuron development and link the effect of a neurotransmitter receptor to the remodeling of the cytoskeleton.

Strikingly, it has been reported that GlyR alpha 2 KO animals (GlyRa2^-^/^-^) do not display any evident morphological disruption of the cortex at postnatal day 0 (P0; [@B132]). Moreover, in these animals, Notch1, Id2, Btg2, TUG1, and GABA~A~R subunit 6 expression appeared to be completely normal around birth, suggesting that GlyR alpha 2 subunit was not required for the acquisition of the main morphological and biochemical features of the cortex ([@B132]). The absence of morphological defects was suspected to arise from compensatory up-regulation of other GlyR or GABA~A~R subunits in GlyRa2^-^/^-^ animals. In this regard, it is interesting to note that GlyRa2^-^/^-^ animals displayed glycine elicited responses at P7 ([@B132]), suggesting that other GlyR subunits could still be necessary for postnatal development. A possible candidate is the GlyR alpha 3 gene, which has been found selectively expressed in layer 2/3 of the adult cortex ([@B115]). Recently, re-analysis of a new GlyRa2^-^/^-^ mouse line has revealed a marked dysfunction in interneuron development. GlyR alpha2 deficient mice were found to have fewer cortical interneurons that migrated at a lower speed while navigating the sub-ventricular zone (SVZ) at the E15 ([@B3]). This defect was previously unnoticed, most probably due to the methodology applied in the early studies. Interneurons are about 15% of the total number of neurons in the cortex ([@B107]) and even a marked reduction in their number is likely to be unnoticed using classical histological methods. Nevertheless, cortical interneurons play an active role controlling cortical excitability ([@B111]) and have been proposed to be fundamental in starting immature circuits ([@B8]). Moreover, their dysfunction has been associated with the development of different brain pathologies ([@B18]; [@B40]; [@B16]; [@B80]).

Apart from its involvement in the control of cell migration, GABA has been involved in the control of cell proliferation as well ([@B105]). In this regard, actions of glycine or taurine are much less explored, but it has been shown that certain brain neuronal progenitors also express GlyRs ([@B89]). Thus, glycine or taurine could also contribute to the neurogenesis process in the brain. Indeed, knockdown of GlyRs in the spinal cord induced an increase in the number of mitotic cells ([@B84]) arguing in favor of a role of glycine in cell cycle regulation.

GLYCINE RECEPTORS DURING POSTNATAL BRAIN DEVELOPMENT
====================================================

After birth, cell proliferation is restricted to small areas in the brain while intense neuronal migration stops to allow final cell positioning, morphological differentiation, and synaptogenesis. At this age, GlyR alpha 2 and beta transcripts are abundant in the cortex and other brain structures ([@B77]; [@B95]). However, there is a dynamic change in levels of expression of these mRNAs during the first two postnatal weeks of development. At the first postnatal day (P0), the alpha 2 and beta transcripts can be detected throughout the whole cortex, the thalamus, and the hippocampus ([@B64]; [@B77]). Complementary studies have found a homogeneous expression of alpha 2 and beta subunits in CP and Cajal--Retzius cells at this age ([@B95]). Later during development, at P5, alpha 2 subunits have been detected specifically in layers I/II and IV while the beta mRNA probe displayed a preferential labeling of layers I/II and VI in the cortex. Moreover, the evidence suggests that this pattern keeps on changing during the next 10 days and by P15 it reaches what resembles the adult distribution. At this age, while the alpha 2 transcripts display strong labeling in layer VI, the beta transcripts are detected in all the layers of the cortex, the hippocampus and the cerebellum ([@B77]). In addition, the transcripts for the alpha 1 and alpha 3 subunits are also detected in the brain after the second postnatal week of development ([@B77]; [@B115]). With respect to the drastic decrease of GlyR alpha 2 subunit in the brain it has been suggested that alpha 2 subunit containing receptors could gradually been replaced by alpha 1/beta heteromers, similarly to what happens in the spinal cord. However, recent analyses, at the protein level have shown that the increase in alpha 1 subunit is so small that it could hardly replace the expression of the alpha 2 subunit, which seems to minimally decrease after birth ([@B51]). This is in line with functional studies that support the expression of homomeric alpha 2 containing receptors in the adult hippocampus ([@B15]).

CORTICAL GLYCINE RECEPTORS
--------------------------

Several electrophysiological experiments have explored the functionality and pharmacological properties of GlyRs in the postnatal cortex ([@B36]; [@B65]). Specifically, by using patch clamp experiments, it has been shown that both Cajal--Retzius cells and CP neurons express functional GlyRs. Interestingly, GlyR-elicited currents were three times larger in Cajal--Retzius cells compared to CP neurons at the same age ([@B95]). Despite the evident difference, there were no other pharmacological or molecular differences in terms of GlyR response or subunit composition, which suggested that GlyRs in both cell types may consist of alpha 2/beta heteromeric receptors at least during the first postnatal days ([@B95]). Functional GlyRs, with similar subunit composition, have also been described in subplate (SP) neurons, where cells respond with less affinity to taurine compared to glycine and beta-alanine in the same way as it has been shown for CP and Cajal--Retzius cells ([@B58]). Activation of GlyRs in the postnatal brain can cause different biological effects depending on the cell type. During early postnatal ages, application of glycine to CP neurons in voltage-clamp mode induces a sustained current along with intense postsynaptic current events ([@B36]). This neurotransmitter release facilitation seems to persist in the developing visual cortex even after the third postnatal week ([@B65]). In contrast to these studies, the application of glycine to Cajal--Retzius cells induces a shunting inhibition of evoked action potentials, hence blocking synaptic transmission ([@B59]). A key factor during the establishment of the first synapses in the cortex is the arrival of extra cortical inputs carried by thalamo-cortical axons. These axons primarily innervate SP neurons, which subsequently transfer the information to the rest of the layers in the cortex. It has been shown that GlyRs present in those cells display properties similar to those of receptors present in the CP, and upon activation they depolarize the cells lowering the threshold for the generation of action potentials ([@B58]). An interesting possibility that arises from this study is that the depolarization induced by GlyRs activation can subsequently also modulate neuronal activity in downstream cortical networks ([@B31]) and influence their development.

HIPPOCAMPAL GLYCINE RECEPTORS
-----------------------------

Functional GlyRs are also found in other regions of the brain. In the developing hippocampus, GlyRs have been reported to be composed by alpha 2/beta heteromeric and alpha 2 homomeric receptors ([@B119]). Interestingly, they have been found on pyramidal neurons from the regions CA1 and CA3 ([@B50]; [@B57]) and also on Mossy fibers boutons ([@B63]). Physiological consequences of GlyRs activation have been demonstrated to be developmentally regulated and to contribute sequentially to depolarization and hyperpolarization in the CA3 region ([@B50]). This depolarization effect converts into hyperpolarizing around P7 and occurred at the same time of the shift in the action of GABA in agreement with the similar chloride conductance characteristic of GABA and glycine ionotropic receptors ([@B50]). Despite of that, depolarizing actions of glycine through the activation of GlyRs can be found later in the CA1 region of the hippocampus during and after the third postnatal week ([@B114]; [@B17]). In fact, the postnatal inhibitory shift depends on the region under investigation (see below). The consequences of the early depolarization exerted by GlyRs are not clear, but they include modulation of receptor trafficking at the synapse ([@B17]) and facilitation of neurotransmitter release. Moreover, extrasynaptic GlyRs contribute to membrane depolarization, tonic inhibition, and long-term depression in the CA1 region ([@B114]; [@B57]; [@B129]; [@B17]). Furthermore, GlyRs have been found on Mossy fiber boutons ([@B63]) and hilar synaptic terminals, where they enhance excitatory activity ([@B68]).

CEREBELLAR GLYCINE RECEPTORS
----------------------------

In the cerebellum, GlyRs have been found functionally expressed on Golgi ([@B26]), granular ([@B54]), and Purkinje cells during the first two postnatal weeks ([@B55]). Additionally, they have also been found in the deep cerebellar nuclei, where they contribute to synaptic ([@B97]) and extra synaptic ([@B56]) transmission. Interestingly, pharmacological experiments suggest the involvement of alpha 2 homomeric receptors in cerebellar synapses at P7--P10 ([@B97]). This is particularly interesting since it is assumed that synaptic GlyRs are heteromeric receptors ([@B60]). As it has been described in other brain structures, GlyR activation increases the frequency of excitatory and inhibitory postsynaptic currents facilitating neurotransmitter release in the cerebellum ([@B55]). These effects were developmentally regulated and peaked at P5 for EPSCs and at P9 for IPSCs ([@B55]). Moreover, these effects were sensitive to TTX, suggesting the involvement of actions potentials and upstream activation of granular cells. This is supported by a previous study that has documented the presence of GlyRs in extra synaptic locations on granular cells ([@B54]). Synaptic GlyRs have also been found on Golgi cells early during development ([@B26]). However, their glycinergic inputs and the consequences of GlyR activation for the cerebellar network are currently unknown.

THALAMIC GLYCINE RECEPTORS
--------------------------

In the thalamus, despite the clear labeling of this structure by GlyR probes ([@B64]; [@B77]), their physiological function has only recently been studied. Remarkably, GlyRs have been found to be involved in more than half of the inhibitory synapses recorded in the ventrobasal thalamic nuclei. This function was observed at P13 in the rat brain and, although there is no certainty regarding any developmental function, it highlights the contribution of GlyRs to thalamic inhibition during development ([@B39]).

NETWORK FORMATION AND GLYCINE RECEPTORS
---------------------------------------

The development of the spinal cord and brainstem provides an intriguing example that involves GlyRs in circuit development. There, synaptic transmission changes from being predominantly GABAergic to glycinergic ([@B62]; [@B38]; [@B103]). This change consists of a presynaptic modification ([@B88]; [@B87]), but it also includes the replacement of alpha 2 with alpha 1 containing GlyRs. Transient expression of GABAergic neurotransmission has been extensively studied in the spinal cord ([@B38]) and it raises the question whether this is a more general phenomenon that can also occur in the brain. Indeed, GlyRs have been found co-localizing with GABAergic terminals in the hippocampus ([@B11]; [@B23]) and in the primate cerebellum ([@B21]). Moreover, functional mixed synapses have been recorded in this brain region ([@B29]; [@B28]). Thus, since mixed synapses may be found during the transition between GABAergic to glycinergic transmission, future research aimed to understand the development of glycinergic synapses should clarify if this transition also occurs in the brain. Nevertheless, mixed synapses may contribute to the development and plasticity of the brain by affecting the functioning of specific circuits as it has been shown in the cerebellum ([@B29]; [@B28]). It is believed that GABAergic activity in mixed developing glutamatergic terminals promotes the development of excitatory connections ([@B43]). Consequently, the presence of mixed synapses during development could be an effective mean to support the development of fast glycinergic neurotransmission. This could be particularly relevant if the developmental functions of GABA are exclusive and cannot be taken over by the activation of GlyRs. This is likely to be the case since it has been shown that GABAergic neurotransmission does not compensate for impaired glycinergic signaling at synaptic sites ([@B86]). On the other hand, GABAergic transmission can modify the function of glycine and GlyRs at mixed synaptic sites and provide specialized mechanisms to control excitability. In line with this, it has been shown that GABA can modulate GlyRs activation in the developing brain cortex ([@B12]). This modulation was only in one direction and while glycine-evoked currents were inhibited by GABA, GABA-evoked currents were only marginally affected by glycine. Similarly, cross inhibition of GABA~A~Rs and GlyRs have also been observed in the hippocampus, but occurring through a different mechanism involving the activation of both receptors ([@B71]). Additionally, direct action of GABA on GlyRs should increase the complexity of glycinergic synapses in the brain ([@B73]; [@B112]).

The transition from slow GABAergic events to faster inhibitory glycinergic activity highlights the fact that network development may need transient, but sustained excitation. In addition, this can be enhanced by the slow decay time associated to certain GABA~A~Rs ([@B30]) and to alpha 2 homomeric GlyRs, present in the immature brain. It is believed that the slow decay of GABA-elicited currents may contribute initially to achieve a long depolarization and to rise cytoplasmic calcium levels that in turn may promote dendrite and spine development ([@B82]; [@B61]) as well as synaptic stabilization and refinement ([@B122]). Indeed, it has been demonstrated that GABAergic depolarization precedes glutamatergic activity and promotes the establishment of synaptic circuits in some regions of the brain ([@B5]; [@B46]; [@B42]; [@B8]). However, this is not a general rule as the opposite have been found in some regions of the cortex ([@B1]). Nevertheless, by homology to GABA~A~Rs, GlyRs may contribute to network formation in the regions where sustained depolarization is needed.

Finally, considering the important role of interneurons in the establishment of the first brain circuits ([@B20]; [@B108]) and the recently described role of GlyRs in controlling interneuron development ([@B3]), it is tempting to speculate that GlyRs could indirectly modify early patterns of activity and have long lasting consequences in brain activity by affecting the number or positioning of cortical interneurons. GlyR knockout animals will potentially be very useful to understand the consequences of the involvement of GlyRs in circuit formation.

DEPOLARIZING TO HYPERPOLARIZING SHIFT IN GlyRs-MEDIATED ACTIONS
---------------------------------------------------------------

Shift from depolarizing to hyperpolarizing action of glycine and GABA seems to be a general phenomenon and it has been shown to occur earlier in caudal than in more rostral parts of the CNS ([@B32]; [@B7]). Indeed, this shift occurs around birth in the spinal cord ([@B128]), after P3 in the brainstem ([@B113]), after P7 in the cerebellum ([@B13]), around P7--P12 in the CA3 region of the hippocampus ([@B6]; [@B50]; [@B121]) and around P16 in the cerebral cortex ([@B96]; for review see [@B7]). Moreover, depolarizing actions of glycine compared to GABA have been shown to occur at the same time in the spinal cord ([@B128]) brainstem ([@B4]; [@B113]), and the CA3 ([@B50]) and CA1 region of the hippocampus ([@B124]; [@B114]; [@B17]). Thus, overall GlyRs seem to be part of the general developmental program of the brain complementing the role of GABA and providing flexibility and specialized mechanisms to control excitation since the early stages of brain development.

GLYCINE RECEPTORS ENDOGENOUS AGONISTS DURING DEVELOPMENT
========================================================

Endogenous activation of GlyRs in the developing cortex occurs through non-synaptic release of neurotransmitters and involves paracrine/autocrine mechanisms ([@B67]). Similar mechanisms operate for GABA and glutamate release contributing to analogous developmental functions ([@B78]; [@B79]). Similarities and differences between various neurotransmitters systems have been extensively covered by [@B67]. Until now, most of the developmental effects associated with glycine were only studied in the spinal cord, but as it has been discussed, glycine and GABA can serve to analogous functions in the developing brain. However, the effect of glycine has its own characteristics and it seems to be complementary to the effect exerted by the activation of GABA~A~Rs. Differences can be found in the control of interneuron migration. There, glycine directly controls interneuron motility ([@B3]) while GABA~A~Rs exclusively affect interneuron pausing time ([@B10]). Moreover, during radial migration, the activation of GABA~A~Rs has an opposite effect compared with the activation of GlyRs. More research is needed to explain these effects. Early studies suggested that taurine could be the endogenous ligand acting on immature GlyRs in the developing cortex. This suggestion was based on the presence of this amino acid in CP neurons ([@B36]), and on the detection of taurine and glycine in adult cortex ([@B123]). However, more recent studies have shown that levels of neurotransmitters can drastically change during the development of the brain and are essentially different from the concentrations found in the adult. While the levels of GABA in the parietal cortex of young adults are 2.6-fold higher than glycine, the levels of this amino acid are three- to fourfold lower than glycine in the embryonic brain. The concentration of taurine progressively increases during embryogenesis, reaching its maximum in the cortex around birth. Comparatively, E13 levels of taurine are 10- and 20-fold higher than the levels of glycine and GABA, respectively ([@B9]). However, it has been shown that cortical GlyRs ([@B59], [@B58]; [@B95]), and specifically homomeric GlyRa2 ([@B110]; [@B24]) are 10 times less sensitive to taurine, which in addition, is only a partial agonist of GlyRs ([@B110]; [@B47]; [@B59], [@B58]; [@B95]). Moreover, it is worth noting that GlyRs affinity for their ligand can substantially increase due to RNA editing or splicing ([@B70]). Altogether, this evidence suggests that both neurotransmitters, glycine and taurine, could act as ligands of GlyRs at various time points and locations during cortical development. In fact, we found that glycine is the main endogenous GlyRs agonist that promotes interneuron migration in the developing cortex and that taurine contributes to this process independently of GlyRs activation ([@B3]). In this study, glycine was found to be produced by immature projection neurons in the CP. Neuronal control of glycine has also been observed in the adult hippocampus ([@B130]), where it has been suggested that neurons could be a more important factor in the control of glycine compared to astrocytes, which have been classically involved in uptake of glycine. Despite of this, astrocytic release of glycine is important in the cortex and hippocampus, where it supports tonic inhibition by activation of GlyRs later during postnatal development ([@B135]; [@B65]). The extracellular level of glycine in the brain is controlled by the glycine transporter one (GlyT1), which is abundantly expressed ([@B22]).

Glycine transporters appear early during embryonic brain development in the rat ([@B52]). GlyT1 is predominant in the embryonic cortex and can be detected in radial glial cells ([@B52]). Although, to our knowledge, no developmental function has been given to this transporter at this age, its expression in radial glial cells suggest that these cells may play an important role by controlling the extracellular level of glycine through GlyT1. In fact, it has been proposed that this could be the primarily role of GlyT1 during spinal cord development where this transporter is instrumental in the removal of glycine from the extracellular compartment in extra synaptic locations ([@B41]). On the other hand, GlyT2 displays weak expression in the brain cortex and hippocampus, but is more abundant in the cerebellum ([@B53]; [@B52]). Remarkably, the progressive development observed in the spinal cord where GlyT2 increases in expression to regulate the level of glycine in combination with GlyT1 ([@B66]) does not seem to occur in the developing brain. In contrast, later during postnatal development glycine level is exclusively controlled by GlyT1 independently of GlyT2 in the cortex ([@B41]; [@B65]). Similar findings are observed in the hippocampus where the prominent function of GlyT1 found at P2 ([@B35]) is also present in the adult formation ([@B81]; [@B130]). Nevertheless, GlyT2 is expressed by hippocampal interneurons and may contribute to additional functions ([@B23]; [@B114]).

During postnatal development, high performance liquid chromatography measurements have described another shift in the concentration of inhibitory neurotransmitters. According to these measurements, after a peak around birth, the levels of taurine remain high and rather constant during the first postnatal week. Then, taurine concentration decreases, but at P15 it still remains two and five times higher than GABA and glycine ones, respectively ([@B117]; [@B9]). Functional experiments carried out at P6 demonstrate that taurine mainly activates glycine and not GABA receptors in the CP ([@B131]). The twofold increase in the level of glycine during embryogenesis reaches a peak around birth and gradually decreases during the first 2 weeks of postnatal development to about 60% of its original peak value. Interestingly, at this age certain components of the glycine cleavage system (GCS) are highly expressed in the cortex, the cerebellum, and the hippocampus ([@B48]; [@B67]). This suggests that GABA and GlyRs could have an important role during a period of intense synaptogenesis. In addition, the fact that taurine levels remain above GABA and glycine even after the first 2 weeks of postnatal development, when GlyRs are activated almost exclusively by glycine ([@B131]), suggests that taurine could serve other functions independently of the sole activation of glycine or GABA receptors in the postnatal brain. Indeed, taurine is known to contribute to many different cellular functions in various physiological contexts, often by an unknown molecular mechanism ([@B106]). Relevant targets for taurine during postnatal development may include KCC2, which is inhibited by taurine, preventing its earlier activation and the anticipated inversion of the chloride gradient ([@B49]). Thus, once again, this evidence suggest that both neurotransmitters, glycine and taurine, could act as ligands of GlyRs depending on the time and place of occurrence during brain development. Furthermore, they could have differential effects at prenatal and postnatal ages.

PATHOPHYSIOLOGICAL CONSEQUENCES OF GlyRs ACTIVATION DURING DEVELOPMENT
======================================================================

While the identity of the endogenous GlyRs ligands remains unclear, both glycine and taurine seem to have an important role during brain development. The concentration of glycine is influenced by the GCS that catalyzes the degradation of glycine and provides the developing brain with other metabolites, such as 5,10-methylenetetrahydrofolate, which is essential for DNA synthesis. Failure in GCS activity leads to serious malformations, such as agenesis of the corpus callosum, gyral malformation and cerebellar hypoplasia. Interestingly, mutations of the AMT gene, encoding an enzyme essential for the degradation of glycine, have been found in two autistic patients ([@B133]). This finding is particularly interesting because it links a developmentally associated pathology with the levels of glycine. Complementarily, deprivation of taurine during pregnancy leads to abnormal cortical development in kittens ([@B117], [@B118]). Other aspects regarding the physiological role of glycine and taurine have recently been reviewed by [@B67].

Although the role of GlyRs activation during early stages of brain development is yet unclear, there is increasing evidence to hypothesize that GlyRs could be involved in a multitude of cellular processes during development. Depending on that, there are multiple neurodevelopmental associated pathologies in which this receptor could play a role. Mutations of GlyRs are mostly present in the adult GlyR alpha 1 gene, which is almost completely absent during development. However, it has recently been found that a single mutation in the GlyR alpha 2 gene may lead to autism ([@B98]). This is a missense mutation where an arginine residue is replaced by a leucine (R350L) in the intracellular loop. Although this mutation was found in a female patient, where there are two copies of the gene, one on each X chromosome, the change on the receptor might have a consequence over particular aspects of her disorder. In the case of autism and schizophrenia, another disorder with a developmental component, it has been suggested that the interaction between multiple gene variants rather than one individual mutation is the most likely scenario that originates the disease. Moreover, it has recently been found that GlyR alpha 2 gene is enriched in serotoninergic neurons, which are known to be involved in autism and related disorders ([@B27]). Thus, GlyR alpha 2 gene has been proposed as a strong candidate for further screening in autistic patients ([@B98]). Along this line, recent findings that describe a role of GlyRs in controlling interneurons migration during embryonic brain development offer a frame to investigate GlyRs on interneuron related disorders ([@B3]). GABAergic transmission and the appropriate development of cortical interneurons contribute to the right functioning of cortical circuits ([@B111]), and defects on these processes are part of the pathophysiology of schizophrenia, autism, and epilepsy ([@B18]; [@B40]; [@B16]; [@B80]). It is possible therefore that GlyRs can play a role in these disorders. A more in depth analysis of GlyR alpha 2 KO animals is necessary to address this possibility. In addition, the affinity of GlyRs for glycine or taurine can be markedly increased by alternative splicing or RNA editing in temporal lobe epilepsy ([@B34]; [@B70]). This is believed to be dependent on the time course of the disease and to affect its evolution. Thus, future research should clarify the role of these variants during development and in neurodevelopmental disorders.

CONCLUSIONS
===========

Glycine receptors can be found prominently expressed in the brain and especially during early stages of development. Their expression has been reported since early embryonic stages where they may contribute to different processes (**Figure [1](#F1){ref-type="fig"}**). Remarkably, recent studies have presented conclusive evidence supporting a role in the control of cell migration. This role seems to be complementary to the activation of GABA receptors that have long been known to contribute in this process. After birth, GlyRs can be found in different structures of the brain displaying a regional differential expression. Although their role in these structures remains unclear, evidence suggest that they may be part of the developmental process in the cortex, hippocampus, cerebellum, and the thalamus. Nevertheless, there is sufficient evidence to consider GlyRs as an important factor controlling neurotransmitter release during postnatal brain development. Consequently, GlyRs may influence the generation of early patterns of activity and the structure of brain circuits. Pathological consequences derived from the malfunction of GlyRs during development are yet to be clarified, but these channels are promising candidates for future research that might offer explanation to rare or complex syndromes that undermine human brain function since early stages of development.

![**Glycine receptors and brain development.** Glycine receptors control different processes during pre and postnatal development of the brain. During embryonic development, studies suggest that GlyRs are involved in neurotransmitter release and the control of cell migration. Migrating interneurons are schematized in green while radially migrating cells are shown in orange. Postnatal functions depend on the depolarizing or hyperpolarizing action downstream GlyRs activation. Initially, GlyRs mediate excitation and promote neurotransmitter release and synaptic communication. Later, GlyRs act as inhibitory and take part in inhibitory synapses. E, embryonic day; P, postnatal day, CR, Cajal--Retzius cells; PP, pre-plate; CP, cortical plate; SVZ, sub-ventricular zone; VZ, ventricular zone; IZ, intermediate zone; GlyRs, glycine receptors; V, voltage; I, current; IPSCs, inhibitory postsynaptic currents.](fncel-07-00184-g001){#F1}
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